Motivation and placebos: Do different mechanisms occur in different contexts?

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 366, Issue 1572, 2011, Pages 1828-1837

  Hyland, Michael E ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Clinical; Expectancy; Motivation; Placebo; Psychoneuroimmunology; Review

Indexed keywords

DRUG; IMMUNE RESPONSE; LITERATURE REVIEW; PSYCHOLOGY;

ARTICLE; HUMAN; MOTIVATION; PLACEBO EFFECT; PSYCHOLOGICAL MODEL;

GOALS; HUMANS; MODELS, PSYCHOLOGICAL; MOTIVATION; PLACEBO EFFECT;

EID: 79956374418     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2010.0391     Document Type: Article

References (54)

1. Kirsch, I. 1985 Response expectancy as a determinant of experience and behavior. Am. Psychol. 40, 1189-1202. (doi:10.1037/0003-066X.40.11.1189)
2. Stewart-Williams, S. & Podd, J. 2004 The placebo effect: dissolving the expectancy versus conditioning debate. Psychol. Bull. 130, 324-340. (doi:10.1037/0033-2909.130.2.324)
3. Kirsch, I. & Hyland, M. E. 1987 How thoughts affect the body: a metatheoretical framework. J. Mind Behav. 8, 417-434. See http://www.umaine.edu/jmb/archives/volume8/8_3_1987summer.html.
4. Powers, W. T. 1978 Quantitative analysis of purposive systems: some spadework at the foundations of scientific psychology. Psychol. Rev. 85, 417-435. (doi:10.1037/0033-295X.85.5.417)
5. Hyland, M. E. 1988 Motivational control theory: an integrative framework. J. Pers. Soc. Psychol. 55, 642-651. (doi:10.1037/0022-3514.55.4.642)
6. Atkinson, J.W. 1964 An introduction to motivation. Princeton, NJ: Van Nostrand.
7. Sheldon, K. M. & Elliot, A. J. 1999 Goal striving, need satisfaction, and longitudinal well-being: the self-concordance model. J. Pers. Soc. Psychol. 76, 482-497. (doi:10.1037/0022-3514.76.3.482)
8. Deci, E. L. & Ryan, R. M. 1985 Intrinsic motivation and self-determination in human behavior. New York, NY: Plenum Press.
9. Gollwitzer, P. M. & Wicklund, R. A. 1985 The pursuit of self-defining goals. In Action control: from cognition tobehavior (ed. K. J. Beckmann), pp. 61-85. New York, NY: Springer.
10. Whalley, B. & Hyland, M. E. 2009 One size does not fit all: Motivational predictors of contextual benefits of therapy. Psychol. Psychother. Theory Res. Pract. 82, 291-303. (doi:10.1348/147608309X413275)
11. Hyland, M. E., Geraghty, A. W. A., Joy, O. E. T. & Turner, S. I. 2006 Spirituality predicts outcome independently of expectancy following flower essence selftreatment. J. Psychosom. Res. 60, 53-58. (doi:10.1016/j. jpsychores.2005.06.073)
12. Hyland, M. E., Geraghty, A. W. A. & Whalley, B. 2007 Dispositional predictors of placebo responding: a motivational interpretation of flower essence and gratitude therapy. J. Psychosom. Res. 62, 331-340. (doi:10.1016/j.jpsychores.2006.10.006)
13. Hyland, M. E. & Whalley, B. 2008 Motivational concordance: an important mechanism in self-help therapeutic rituals involving inert (placebo) substances. J. Psychosom. Res. 65, 405-441. (doi:10.1016/j.jpsychores.2008.02.006)
14. Antonovsky, A. 1987 Unraveling the mystery of health. San Francisco, CA: Josse-Bass.
15. Hyland, M. E. 1987 Control theory interpretation of psychological mechanisms of depression: comparison and integration of several theories. Psychol. Bull. 102, 109-121. (doi:10.1037/0033-2909.102.1.109)
16. Carver, C. S. & Scheier, M. F. 1990 Origins and functions of positive and negative affect: a control-process view. Psychol. Rev. 97, 19-35. (doi:10.1037/0033-295X.97.1.19)
17. Irwin, R. R. & Miller, A. H. 2007 Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 21, 374-383. (doi:10.1016/j.bbi. 2007.01.010)
18. Irwin, R. R. 2008 Human psychoneuroimmunology: 20 years of discovery. Brain Behav. Immun. 22, 129-139. (doi:10.1016/j.bbi.2007.07.013)
19. Segerstrom, S. C. & Miller, G. E. 2004 Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130, 601-630. (doi:10.1037/0033-2909.130.4.601)
20. Hoppmann, C. A. & Klumb, P. L. 2006 Daily goal pursuits predict cortisol secretion and mood states in employed parents with preschool children. Psychosom. Med. 68, 887-894. (doi:10.1097/01.psy.0000238232.46870.f1)
21. Kemeny, M. E. & Schedlowski, M. 2007 Understanding the interaction between psychosocial stress and immunerelated diseases: a stepwise progression. Brain Behav. Immun. 21, 1009-1018. (doi:10.1016/j.bbi.2007.07.010)
22. Kasser, T. & Ryan, R. M. 1993 A dark side of the American dream: correlates of financial success as a central life aspiration. J. Pers. Soc. Psychol. 70, 395-407. (doi:10.1037/0022-3514.65.2.410)
23. Carver, C. S. & Baird, E. 1998 The American dream revisited: is it what you want or why you want it that matters? Psychol. Sci. 9, 289-292. (doi:10.1111/1467-9280. 00057)
24. Totman, R. 1975 Cognitive dissonance and the placebo response: the effect of differential justification for undergoing dummy injections. Eur. J. Social Psychol. 5, 441-456. (doi:10.1002/ejsp.2420050403)
25. Jensen, M. P. & Karoly, P. 1991 Motivation and expectancy factors in symptom perception: a laboratory study of the placebo effect. Psychosom. Med. 53, 144-152. See http://www.psychosomaticmedicine.org/cgi/content/abstract/53/2/144.
26. Aletky, P. J. & Carlin, A. S. 1975 Sex differences and placebo effects: motivation as an intervening variable. J. Consult. Clin. Psychol. 43, 278. (doi:10.1037/h0076384)
27. Price, D. D., Milling, L. S., Kirsch, I., Duff, A., Montgomery, G. H. & Nicholls, S. S. 1991 An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83, 147-156. (doi:10.1016/S0304-3959(99)00081-0)
28. Nakano, S., Sugahara, H., Sakamoto, M., Ozeki, T., Uemura, BN., Nyu, S., Sunami, Y., Matsuki, S. & Umetsuki, M. 1999 Factors influencing placebo effects in patients with psychosomatic disorders: doctor-patient relationship, patient's motivation and expectation for drug therapy. Jpn. J. Clin. Pharmacol. Therapeut. 30, 1-7. http://sciencelinks.jp/j-east/article/199916/000019991699A0323961.php.
29. Vase, L., Robinson, M. E., Verne, G. N. & Price, D. D. 2005 Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 115, 338-347. (doi:10.1016/j.pain.2005.03.014)
30. Vase, L., Robinson, M. E., Verne, G. N. & Price, D. D. 2003 The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients: an empirical investigation. Pain 105, 17-25. (doi:10.1016/S0304-3959(03)00073-3)
31. Geers, A. L., Weiland, P. E., Kosbab, K., Landry, S. J. & Hefner, S. G. 2005 Goal activation, expectations, and the placebo effect. J. Pers. Soc. Psychol. 89, 143-159. (doi:10.1037/0022-3514.89.2.143)
32. Walach, H., Rilling, C. & Engelke, U. 2001 Efficacy of Bach-flower remedies in test anxiety: a double-blind, placebo-controlled, randomized trial with partial crossover. J. Anxiety Disord. 15, 359-366. (doi:10.1016/S0887-6185(01)00069-X)
33. Brody, H. 2000 The placebo response. New York, NY: Harper Collins.
34. Geers, A. L., Helfer, S. G., Kosbab, K., Weiland, P. E. & Landry, S. J. 2005 Reconsidering the role of personality in placebo effects: Dispositional optimism, situational expectations, and the placebo response. J. Psychosom. Res. 58, 121-127. (doi:10.1016/j.jpsychores.2004.08.011)
35. Loeser, J. D. & Melzack, R. 1999 Pain: an overview. Lancet 353, 1607-1609. (doi:10.1016/S0140-6736(99) 01311-2)
36. Bandura, A., O'Leary, A., Taylor, C. B., Gauthier, J. & Gossard, D. 1987 Perceived self-efficacy and pain control: opioid and nonopioid mechanisms. J. Pers. Soc. Psychol. 53, 563-571. (doi:10.1037/0022-3514.53.3.563)
37. Amanzio, M., Poll, A., Maggi, G. & Benedetti, F. 2001 Bottom of form response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain 90, 205-215. (doi:10.1016/S0304-3959(00)00486-3)
38. Kemeny, M. E., Rosenwasser, L. J., Panettieri, R. A., Rose, R. M., Berg-Smith, S. M. & Kline, J. N. 2007 Placebo response in asthma: a robust and objective phenomenon. J. Allergy Clin. Immunol. 119, 1375-1381. (doi:10.1016/j.jaci.2007.03.016)
39. Ritz, T., Rosenfield, D., DeWilde, S. & Steptoe, A. 2010 Daily mood, shortness of breath, and lung function in asthma: concurrent and prospective associations. J. Psychosom. Res. 69, 341-351. (doi:10.1016/j.jpsychores. 2010.05.004)
40. Moyer, C. A., Rounds, J. & Hannum, J. W. 2004 A metaanalysis of massage therapy research. Psychol. Bull. 130, 3-18. (doi:10.1037/0033-2909.130.1.3)
41. Wampold, B. E. 2001 The great psychotherapy debate: models, methods, and findings. Mahwah, NJ: Lawrence Erlbaum.
42. Thomas, K. B. 1987 General practice consultations: is there any point in being positive? Br. Med. J. 294, 1200-1202. (doi:10.1136/bmj.294.6581.1200)
43. Ellis, R. & Humphries, G. W. 1999 Connectionist psychology. Hove, UK: Psychology Press. 1836
44. Mazzoni, G., Hyland, M. E., Foan, L. & Kirsch, I. 2010 The effects of observation and gender on psychogenic symptoms. Health Psychol. 29, 181-185. (doi:10.1037/a0017860)
45. Kelly, J. M. 2008 The relation between motivational concordance and response expectancy. J. Psychsom. Res. 65, 415-416. (doi:10.1016/j.jpsychores.2008.05.001)
46. Hyland, M. E. 2011 The origins of health and disease. Cambridge, UK: Cambridge University Press.
47. TheMTACooperative Group 1990 A 14-month randomized clinical trial of treatment strategies for attentiondeficit/hyperactivity disorder. Arch. Gen. Psychiatry 56, 1073-1086. (doi:10.1001/archpsyc.56.12.1073)
48. The MTA Cooperative Group 1999 Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiat. 56, 1088-1096. (doi:10.1001/archpsyc.56.12.1088)
49. Whalley, B. et al. 2011 Psychological interventions for coronary heart disease. Cochrane Database Syst. Rev. 2, CD002902. (doi:10.1002/14651858.CD002902.pub2)
50. Coyne, J. C., Stefanek, M. & Palmer, S. C. 2007 Psychotherapy and survival in cancer: the conflict between hope and evidence. Psychol. Bull. 133, 367-394. (doi:10.1037/0033-2909.133.3.367)
51. Temel, J. S., Greer, J. A. & Muzikansky, A. 2010 Early palliative care for patients with metastatic non-smallcell lung cancer. N. Engl. J. Med. 363, 733-742. (doi:10.1056/NEJMoa1000678)
52. Osman, L. M. & Hyland, M. E. 2005 Adherence and self management. In Evidence based respiratory medicine (eds P. Gibson,M.Abramson,U.Costabel,M.Hensley, J. Volmink & R.Wood-Baker), pp. 91-105. London,UK: BMJ Books.
53. Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A. & Thompson, A. 2003 Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomized placebo-controlled trial. The Lancet 362, 1517-1526. (doi:10.1016/S0140-6736(03)14738-1)
54. Kirsch, I. 2009 The emperor's new drugs: exploding the antidepressant myth. London, UK: The Bodley Head.